Marcelin; Anne-Genevieve

Patent Applications and Registrations

Patent applications and USPTO patent grants for Marcelin; Anne-Genevieve.The latest application filed is for "meclozine derivatives and diclazuril derivatives for use in the prevention and/or the treatment of disorders associated to the inflammation induced by p. acnes".

Company Profile

0.6.5

Marcelin; Anne-Genevieve - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Meclozine derivatives and diclazuril derivatives for use in the prevention and/or the treatment of disorders associated to the inflammation induced by P. acnes Grant 11,116,763 - Dupin , et al. September 14, 2	2021-09-14
Capped cyclodextrin-hydrophobic moiety conjugate, cyclodextrin supramolecular polymer, and cyclodextrin-siRNA complex and method of synthesis thereof Grant 10,947,323 - Sollogoub , et al. March 16, 2	2021-03-16
Meclozine Derivatives And Diclazuril Derivatives For Use In The Prevention And/or The Treatment Of Disorders Associated To The Inflammation Induced By P. Acnes App 20200383973 - Dupin; Nicolas ; et al.	2020-12-10
Hycanthone derivatives and Primaquine derivatives for use in the prevention and/or the treatment of disorders associated to gammaherpesvirus Grant 10,842,776 - Dupin , et al. November 24, 2	2020-11-24
CAPPED CYCLODEXTRIN-HYDROPHOBIC MOIETY CONJUGATE, CYCLODEXTRIN SUPRAMOLECULAR POLYMER, AND CYCLODEXTRIN-siRNA COMPLEX AND METHOD App 20200010576 - SOLLOGOUB; Matthieu ; et al.	2020-01-09
Meclozine Derivatives And Diclazuril Derivatives For Use In The Prevention And/or The Treatment Of Disorders Associated To The I App 20190224191 - Dupin; Nicolas ; et al.	2019-07-25
Hycanthone Derivatives And Primaquine Derivatives For Use In The Prevention And/or The Treatment Of Disorders Associated To Gammaherpesvirus App 20190125723 - Dupin; Nicolas ; et al.	2019-05-02
Nucleoside analogues for the treatment of a viral infection, and method for evaluating the sensitivity to said treatment Grant 9,181,294 - Calvez , et al. November 10, 2	2015-11-10
Use of interfering rna for treating an hiv infection Grant 9,127,279 - Calvez , et al. September 8, 2	2015-09-08
Use Of Interfering Rna For Treating An Hiv Infection App 20120095082 - Calvez; Vincent ; et al.	2012-04-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.